BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 18605974)

  • 1. Papillomaviruses--to vaccination and beyond.
    zur Hausen H
    Biochemistry (Mosc); 2008 May; 73(5):498-503. PubMed ID: 18605974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.
    Cheng MA; Farmer E; Huang C; Lin J; Hung CF; Wu TC
    Hum Gene Ther; 2018 Sep; 29(9):971-996. PubMed ID: 29316817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Approaches for Vaccination Against HPV-Induced Cancers.
    King E; Ottensmeier C; Pollock KGJ
    Curr Top Microbiol Immunol; 2017; 405():33-53. PubMed ID: 25735921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developments in L2-based human papillomavirus (HPV) vaccines.
    Schellenbacher C; Roden RBS; Kirnbauer R
    Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV vaccination: the beginning of the end of cervical cancer? - A Review.
    Lepique AP; Rabachini T; Villa LL
    Mem Inst Oswaldo Cruz; 2009 Feb; 104(1):1-10. PubMed ID: 19274369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in genital human papillomavirus infection prevalence and vaccination coverage among men and women in the USA.
    Han JJ; Tarney CM; Song J
    Future Oncol; 2017 Jun; 13(13):1129-1132. PubMed ID: 28589730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV vaccine update: new indications and controversies.
    Mendoza N; Hernandez PO; Tyring SK
    Skin Therapy Lett; 2011 Sep; 16(8):1-3. PubMed ID: 22089414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus: current status and issues of vaccination.
    Malik H; Khan FH; Ahsan H
    Arch Virol; 2014 Feb; 159(2):199-205. PubMed ID: 24022639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current state of therapeutic and T cell-based vaccines against human papillomaviruses.
    Yang A; Farmer E; Lin J; Wu TC; Hung CF
    Virus Res; 2017 Mar; 231():148-165. PubMed ID: 27932207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus vaccination induces neutralising antibodies in oral mucosal fluids.
    Handisurya A; Schellenbacher C; Haitel A; Senger T; Kirnbauer R
    Br J Cancer; 2016 Feb; 114(4):409-16. PubMed ID: 26867163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: current knowledge on the role of HPV antibodies after natural infection and vaccination: implications for monitoring an HPV vaccination programme.
    Mollers M; Vossen JM; Scherpenisse M; van der Klis FR; Meijer CJ; de Melker HE
    J Med Virol; 2013 Aug; 85(8):1379-85. PubMed ID: 23722396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender-neutrality, herd effect and resilient immune response for sustainable impact of HPV vaccination.
    Lehtinen M; Apter D
    Curr Opin Obstet Gynecol; 2015 Oct; 27(5):326-32. PubMed ID: 26308204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of immune responses to HPV infection and during HPV-directed immunotherapy.
    Bhat P; Mattarollo SR; Gosmann C; Frazer IH; Leggatt GR
    Immunol Rev; 2011 Jan; 239(1):85-98. PubMed ID: 21198666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and treatment of papillomavirus-related cancers through immunization.
    Frazer IH; Leggatt GR; Mattarollo SR
    Annu Rev Immunol; 2011; 29():111-38. PubMed ID: 21166538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV vaccination and the effects on rates of HPV-related cancers.
    St Laurent J; Luckett R; Feldman S
    Curr Probl Cancer; 2018 Sep; 42(5):493-506. PubMed ID: 30041818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice.
    Wentzensen N; Arbyn M; Berkhof J; Bower M; Canfell K; Einstein M; Farley C; Monsonego J; Franceschi S
    Int J Cancer; 2017 May; 140(10):2192-2200. PubMed ID: 28006858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On surmounting the barriers to HPV vaccination: we can do better.
    Attia AC; Wolf J; Núñez AE
    Ann Med; 2018 May; 50(3):209-225. PubMed ID: 29316825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mothers' acceptance of human papillomavirus (HPV) vaccination for daughters in a country with a high prevalence of HPV.
    Alder S; Gustafsson S; Perinetti C; Mints M; Sundström K; Andersson S
    Oncol Rep; 2015 May; 33(5):2521-8. PubMed ID: 25738832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.
    Guo T; Eisele DW; Fakhry C
    Cancer; 2016 Aug; 122(15):2313-23. PubMed ID: 27152637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Australian HPV vaccination programme yields results.
    Howe M
    Lancet Oncol; 2014 Dec; 15(13):e591. PubMed ID: 25499291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.